Sector portfolio · VC firm · United States
KdT Ventures' Biotech portfolio
KdT Ventures has backed 12 Biotech startups in rounds we track, $528M between them, shown by the stage each has reached. The best-funded is Solugen.
Funding by segment
- Series A$187M5
- Stage not reported$28M4
- Series B$313M3
Where they are based
- United States12$528M
United StatesFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M3
- $10M to $50M7
- $50M to $250M2
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States12
Startups by country, 1 country in all.
Segment by segment
Series A
5 startups · $187M raised
Parthenon TherapeuticsParthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.United States$65M
AzitraAzitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.United States$49M
March BiosciencesMarch Biosciences is a clinical-stage cell therapy company based in Houston, Texas.United States$29M
Faeth TherapeuticsFaeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.United States$25M
Tacit TherapeuticsTacit Therapeutics created RNA-targeting treatments for devastating diseases.United States$19M
Stage not reported
4 startups · $28M raised
Tavros TherapeuticsTavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.United States$18M
Unravel BiosciencesUnravel Biosciences is a clinical-stage therapeutics company based in Medford, Massachusetts, focused on advancing drug developmenUnited States$4.7M
ZymochemZymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials.United States$4.0M
Onc.AIOnc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.United States$2.0M
Series B
3 startups · $313M raised
SolugenDiscover the realm of digital intimacy where connections transcend physical boundaries.United States$246M
ElegenElegen is a biotechnology company founded in 2017 and located in San Carlos/Menlo Park, California.United States$35M
SURGE TherapeuticsSURGE Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on innovative cancer treatUnited States$32M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names KdT Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like KdT Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.